ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

Nanomedcines Open New Avenues for Making Antibiotic Therapy Effective Against Mutidrugs Resistant Bacteria

Updated on January 1, 2020
Muh Imran profile image

Muhammad Imran is a registered pharmacist and PhD in nano drug delivery. He is currently working as research scientist.

Mutlidrugs Resistance and Its Consequences

Antibiotics are important drugs used for the treatment and management of various infectious diseases. They are the drugs of choice for infections caused by pathogenic bacterial strains. When bacteria become insensitive to the lethal doses of antibiotics, they are said to be resistant to antibiotics. Multidrugs resistance is said to occur when pathogenic bacteria become insensitive to lethal doses of multiple antibiotics. Multidrugs resistance developed by bacteria is currently one of the main health concern across the globe as the treatment of various bacterial and fungal infections have become difficult. The statistics of infections caused by multidrug resistant bacteria show that the resistance to antibiotics by bacteria has increased many folds. Reports have highlighted resistance as major threat to human health in Europe. This multidrug resistance is a matter of great concern for health care professionals as it not only results in deaths from infectious diseases, but also leads to economic burden both on the part of the patients as well as health care systems of the countries. In Europe, the rate of mortality enhanced significantly as a consequence of multidrug resistance bacterial infections and causes a loss of €1.5 billion to European economy every year. In United States, 2 million people suffer with antibiotic resistant bacteria each year, with mortality rate of about 23,000 as direct result. The lack of development of new antibiotics has further deteriorated the situation of antibiotics resistance.

How Bacteria Develop Resistance Against Antibiotics

Resistance to antibiotics in bacteria occurs due to irrational use of antibiotics by population, especially in under developed and developing counters. Various mechanisms are exploited by bacteria for developing resistance against antibiotics. These mechanisms include an increase in the drugs efflux system, decrease in the permeability of bacterial membrane, alterations in the antibiotics target proteins and inactivation and degradation of antibiotics by the enzymatic action.

Nanomedicines: A New Era in Drug Delivery

Nanomedicines are currently attracting scientists due to their interesting properties. Nanomedicines exploit the applications of nano size carriers for loading and delivering of drugs. These nano size carriers have unique physico-chemical properties such large surface area, surface engineering and modification, smaller size, higher stability, interactive nature towards biological systems of interest as well as higher physical, chemical and biological stability. They are capable of loading and delivering drugs in increased concentration to target sites, thus maximum therapeutic clinical efficacy is achieved without their side effects. Nano carriers also protect the drugs from enzymatic degradation, instabilities and deactivation.

Nanomedicines as Tools for Reversing Resistance to Antibiotics

Increased drug efflux by bacteria results in their resistance against different antibiotics. Nano size carriers have been used for decreasing or inhibiting the drug efflux system activated by bacteria against a specific antibiotic. These nano carriers are designed in such a way that they disguise the bacteria or their efflux system, thus deliver the antibiotic across the bacterial cell wall.

Some nano carriers are extremely small, thus they are able to cross the cell wall and deliver their loaded antibiotics to the inner of the bacteria. Moreover, various nano systems have been modified with ligands that can effectively interact with specific molecules on bacterial cell wall, thus results in the adherence of the antibiotic loaded nano systems followed by their cross-wall transportation, resulting in the antibiotic improved bactericidal activity.

Recently nano carriers have been materialized that can deliver antibiotics to the resistant bacteria due to their electrostatic interaction with bacterial cell wall. Bacterial wall of Gram-negative bacteria is negatively charged. Positively charged nano carriers systems have been found effective in delivering drugs to these bacteria due to their electrostatic interaction with the negatively charged bacterial cell wall. Many nano systems are inherently bactericidal in nature, thus when they are used for delivery of antibiotics, they cause a synergistic effects with ultimate improved antibiotic therapy. The co-delivery of different antibiotics in a single nano carrier system is also appealing the scientists for decreasing or preventing antibiotic resistance in bacteria. Some nano carriers have also been used for co-delivery of antibiotics with certain natural polyphenols, thus leading to minimization of bacterial resistance against antibiotics.

Recently peptide amphiphiles based nano carriers are of greater scientific interests. Nano carriers formed as a result of self-assembling of peptide amphiphiles into nano scale shapes are used for loading and delivering of antibiotics. Such nano carriers interact with bacterial cell wall due to their micellization effects. Moreover, they can also interact with bacterial cell wall due to their cationic nature. Peptide amphiphiles based nano carriers are also inherently bactericidal in nature, thus they cause synergistic effects for the antibiotics delivered in them. Metal nanoparticles constitute another area of interest for minimizing antibiotic resistance. Silver nanoparticles are antibacterial in nature and they can increase the bactericidal activity of drugs chemically conjugated on their surfaces. Metal nanoparticles are also capable of biofilm inhibition, thus they can effectively inhibit or minimize the bacterial antibiotic resistance.

Future of Nanomedicines

Advent of nanomedicines have opened new avenues for researchers to explore new ways of making antibiotics therapy highly productive and cost-effective. Researchers are trying to make nanomedicines more attractive by inserting in genes recognition ability in nano carriers which ultimately recognize a pathogen of interest.

Comments

    0 of 8192 characters used
    Post Comment

    No comments yet.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: https://maven.io/company/pages/privacy

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)
    ClickscoThis is a data management platform studying reader behavior (Privacy Policy)